| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/MOL.52.5.896 |
| P698 | PubMed publication ID | 9351981 |
| P2093 | author name string | Yabaluri N | |
| Medzihradsky F | |||
| P433 | issue | 5 | |
| P304 | page(s) | 896-902 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling | |
| P478 | volume | 52 |
| Q32027234 | Acute opioid receptor desensitization and tolerance: is there a link? |
| Q22254626 | Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell |
| Q45277210 | Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis |
| Q35688547 | Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice |
| Q36328175 | Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A. |
| Q36155156 | Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition |
| Q44329940 | Effect of morphine on cholecystokinin and mu-opioid receptor-like immunoreactivities in rat spinal dorsal horn neurons after peripheral axotomy and inflammation |
| Q44090367 | Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors. |
| Q41889163 | Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor |
| Q43070751 | G protein-coupled receptor (GPCR) trafficking in the central nervous system: relevance for drugs of abuse |
| Q44014506 | Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat. |
| Q39895195 | Long-term morphine treatment decreases the association of mu-opioid receptor (MOR1) mRNA with polysomes through miRNA23b |
| Q44349884 | Mechanisms of μ-opioid receptor inhibition of NMDA receptor-induced substance P release in the rat spinal cord |
| Q43633492 | Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells |
| Q36341679 | Mu opioid receptor regulation and opiate responsiveness |
| Q43921700 | Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling |
| Q33910436 | Mutational analysis of the structure and function of opioid receptors |
| Q39883445 | Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor |
| Q37831309 | Opioids in chronic non-cancer pain |
| Q44333978 | Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. |
| Q31816606 | Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors |
| Q39275565 | Regulation of mammalian MOR-1 gene expression after chronic treatment with morphine |
| Q44345837 | Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery |
| Q38360431 | Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo |
| Q42713502 | The combination of mitragynine and morphine prevents the development of morphine tolerance in mice |
| Q33714922 | The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy |
| Q39433076 | The influence of active transport systems on morphine -6-glucuronide transport in MDCKII and MDCK-PGP cells |
| Q44329891 | The mu-opioid receptor gene-dose dependent reductions in G-protein activation in the pons/medulla and antinociception induced by endomorphins in mu-opioid receptor knockout mice |
| Q73213332 | [Mechanisms of opioid tolerance and opioid dependence] |
| Q37721910 | μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain |
Search more.